Pharmaceutical News and Articles

Healthy Nutrition, Activity May Reduce Mortality Risk for Cancer Survivors

Adherence to American Cancer Society (ACS) nutrition and activity guidelines for cancer survivors is associated with lower mortality risk among nonsmoking survi

Lower Oral Health Scores Linked to Higher Pain Scores in Women

Low oral health scores are associated with higher pain scores, including migraine headache, among women, according to a study published online April 9 in Fronti

Brain Functional Networks Affected by Neoadjuvant Chemo in Breast Cancer

For patients with breast cancer, the brain functional network shows a shift toward a more randomized pattern after neoadjuvant chemotherapy (NAC), with progress

Link Between Global β-Amyloid, Tau Deposition Varies by Sex

Women and individuals with a paternal history of Alzheimer disease (AD) have a stronger association between global -amyloid (A ) and tau deposition, according t

Two Deaths in Oregon County Linked to Fatal Brain Disorder

MONDAY, April 14, 2025 Health officials in Hood River County, Oregon, are investigating three cases of a rare and fatal brain disease known as Creutzfeldt-Jakob

Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disea

Fisher-Price Recalls 253,000 Baby Toys Over Choking Risk

MONDAY, April 14, 2025 Fisher-Price has recalled 253,000 baby stroller toys in the U.S. because of a choking risk, according to the U.S. Consumer Product Safety

Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Injection

Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that the U.S. Food and Drug

Uplizna (inebilizumab-cdon) is Now the First and Only FDA-Approved Treatment for IgG4-Related Disease